Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             205 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of toll-like receptor signaling pathway for protection against influenza virus infection Wong, J.P.
 2009
 27 Supplement 2 p. 3481-3483
3 p.
 artikel
2 Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein Moorthy, S.A.V.
 2009
 27 Supplement 2 p. 4947-4952
6 p.
 artikel
3 A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms Segalés, J.
 2009
 27 Supplement 2 p. 7313-7321
9 p.
 artikel
4 A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Talaat, Kawsar R.
 2009
 27 Supplement 2 p. 3744-3753
10 p.
 artikel
5 A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy Alvarez-Rueda, Nidia
 2009
 27 Supplement 2 p. 4826-4833
8 p.
 artikel
6 Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer Jasani, B.
 2009
 27 Supplement 2 p. 3401-3404
4 p.
 artikel
7 Analysis of biomarkers after intramuscular injection of Vaxfectin®-formulated hCMV gB plasmid DNA Vilalta, Adrián
 2009
 27 Supplement 2 p. 7409-7417
9 p.
 artikel
8 Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: Methodological difficulties and imperfect solutions De Wals, Philippe
 2009
 27 Supplement 2 p. 3223-3227
5 p.
 artikel
9 An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink Yih, W. Katherine
 2009
 27 Supplement 2 p. 4257-4262
6 p.
 artikel
10 A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults Jin, Xia
 2009
 27 Supplement 2 p. 7080-7086
7 p.
 artikel
11 Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains Malerczyk, Claudius
 2009
 27 Supplement 2 p. 5320-5325
6 p.
 artikel
12 Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine Kitchin, Nicholas
 2009
 27 Supplement 2 p. 5096-5102
7 p.
 artikel
13 Antibody quantity versus quality after influenza vaccination Feng, JingQi
 2009
 27 Supplement 2 p. 6358-6362
5 p.
 artikel
14 Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan Iriemenam, Nnaemeka C.
 2009
 27 Supplement 2 p. 62-71
10 p.
 artikel
15 A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine Cox, Rebecca J.
 2009
 27 Supplement 2 p. 1889-1897
9 p.
 artikel
16 A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals Ellis, Ruth D.
 2009
 27 Supplement 2 p. 4104-4109
6 p.
 artikel
17 A prime–boost vaccination of mice with heterologous H5N1 strains Ikeno, Daisuke
 2009
 27 Supplement 2 p. 3121-3125
5 p.
 artikel
18 A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves Funk, L.
 2009
 27 Supplement 2 p. 4585-4590
6 p.
 artikel
19 A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® +CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults Sagara, Issaka
 2009
 27 Supplement 2 p. 7292-7298
7 p.
 artikel
20 A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali Sagara, Issaka
 2009
 27 Supplement 2 p. 3090-3098
9 p.
 artikel
21 A recombinant replication-defective human adenovirus type 3: A vaccine candidate Li, Haitao
 2009
 27 Supplement 2 p. 116-122
7 p.
 artikel
22 A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period Korematsu, Seigo
 2009
 27 Supplement 2 p. 5041-5042
2 p.
 artikel
23 Ascaris suum infection negatively affects the response to a Mycoplasma hyopneumoniae vaccination and subsequent challenge infection in pigs Steenhard, Nina R.
 2009
 27 Supplement 2 p. 5161-5169
9 p.
 artikel
24 A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells Yamanaka, Atsushi
 2009
 27 Supplement 2 p. 3735-3743
9 p.
 artikel
25 A single immunization with a recombinant canine adenovirus type 2 expressing the seoul virus Gn glycoprotein confers protective immunity against seoul virus in mice Yuan, Zi-Guo
 2009
 27 Supplement 2 p. 5247-5251
5 p.
 artikel
26 A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics Hu, Shunlin
 2009
 27 Supplement 2 p. 904-910
7 p.
 artikel
27 Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice Verma, Shailendra Kumar
 2009
 27 Supplement 2 p. 6905-6909
5 p.
 artikel
28 Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease Frasch, Carl E.
 2009
 27 Supplement 2 p. B112-B116
nvt p.
 artikel
29 Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice Zheng, Nuoyan
 2009
 27 Supplement 2 p. 5001-5007
7 p.
 artikel
30 Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: Benefits of mortality reduction versus risk of fatal intussusception Patel, Manish M.
 2009
 27 Supplement 2 p. 2916-2922
7 p.
 artikel
31 Brucellosis: The case for live, attenuated vaccines Ficht, Thomas A.
 2009
 27 Supplement 2 p. D40-D43
nvt p.
 artikel
32 Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy) Panatto, D.
 2009
 27 Supplement 2 p. 3450-3453
4 p.
 artikel
33 Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes Arankalle, Vidya A.
 2009
 27 Supplement 2 p. 1032-1039
8 p.
 artikel
34 Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human Leonova, Galina N.
 2009
 27 Supplement 2 p. 2899-2904
6 p.
 artikel
35 Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken Xiaowen, Zhang
 2009
 27 Supplement 2 p. 5628-5632
5 p.
 artikel
36 Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Horwitz, Marcus A.
 2009
 27 Supplement 2 p. 441-445
5 p.
 artikel
37 Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens Jadhao, Samadhan J.
 2009
 27 Supplement 2 p. 6247-6260
14 p.
 artikel
38 Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study Schuller, Elisabeth
 2009
 27 Supplement 2 p. 2188-2193
6 p.
 artikel
39 Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes Valentin, Antonio
 2009
 27 Supplement 2 p. 4840-4849
10 p.
 artikel
40 Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination Opriessnig, T.
 2009
 27 Supplement 2 p. 1002-1007
6 p.
 artikel
41 Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge Platt, Ratree
 2009
 27 Supplement 2 p. 4508-4519
12 p.
 artikel
42 Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members Eick, Angelia A.
 2009
 27 Supplement 2 p. 3568-3575
8 p.
 artikel
43 Considerations regarding efficacy endpoints in HIV vaccine trials: Executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine Enterprise Fruth, Uli
 2009
 27 Supplement 2 p. 1989-1996
8 p.
 artikel
44 Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees Garner-Spitzer, Erika
 2009
 27 Supplement 2 p. 197-204
8 p.
 artikel
45 Cost–benefit comparisons of investments in improved water supply and cholera vaccination programs Jeuland, Marc
 2009
 27 Supplement 2 p. 3109-3120
12 p.
 artikel
46 CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice Ribeiro, Dâmaso P.
 2009
 27 Supplement 2 p. 2570-2579
10 p.
 artikel
47 Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen Zhang, Mei-Yun
 2009
 27 Supplement 2 p. 857-863
7 p.
 artikel
48 Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response Kagina, Benjamin M.N.
 2009
 27 Supplement 2 p. 5488-5495
8 p.
 artikel
49 Development and use of SIV-based Integrase defective lentiviral vector for immunization Michelini, Zuleika
 2009
 27 Supplement 2 p. 4622-4629
8 p.
 artikel
50 Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq® Ciarlet, Max
 2009
 27 Supplement 2 p. G72-G81
nvt p.
 artikel
51 Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections Kim, Min-Chul
 2009
 27 Supplement 2 p. 6688-6694
7 p.
 artikel
52 Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status Asturias, Edwin J.
 2009
 27 Supplement 2 p. 3650-3654
5 p.
 artikel
53 Disease and economic burden of rotavirus diarrhoea in India Tate, Jacqueline E.
 2009
 27 Supplement 2 p. F18-F24
nvt p.
 artikel
54 Dose response effects of avian influenza (H7N7) vaccination of chickens: Serology, clinical protection and reduction of virus excretion Maas, Riks
 2009
 27 Supplement 2 p. 3592-3597
6 p.
 artikel
55 Early life DNA vaccination with the H gene of Canine distemper virus induces robust protection against distemper Jensen, Trine Hammer
 2009
 27 Supplement 2 p. 5178-5183
6 p.
 artikel
56 Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment Lederman, Edith
 2009
 27 Supplement 2 p. 375-377
3 p.
 artikel
57 Editorial Board 2009
 27 Supplement 2 p. CO2-
1 p.
 artikel
58 Editorial Board 2009
 27 Supplement 2 p. CO2-
1 p.
 artikel
59 Editorial Board 2009
 27 Supplement 2 p. CO2-
1 p.
 artikel
60 Editorial Board 2009
 27 Supplement 2 p. CO2-
1 p.
 artikel
61 Editorial Board 2009
 27 Supplement 2 p. CO2-
1 p.
 artikel
62 Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2 Kumar, Sachin
 2009
 27 Supplement 2 p. 864-869
6 p.
 artikel
63 Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves Waters, W. Ray
 2009
 27 Supplement 2 p. 1201-1209
9 p.
 artikel
64 Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence Bonanni, Paolo
 2009
 27 Supplement 2 p. A46-A53
nvt p.
 artikel
65 Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine Hsuan, Shih-Ling
 2009
 27 Supplement 2 p. 2923-2929
7 p.
 artikel
66 Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials Rhorer, Janelle
 2009
 27 Supplement 2 p. 1101-1110
10 p.
 artikel
67 Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trials Gilbert, Peter B.
 2009
 27 Supplement 2 p. 396-401
6 p.
 artikel
68 Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2 Duan, Xuefeng
 2009
 27 Supplement 2 p. 6154-6159
6 p.
 artikel
69 Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion Baldwin, Susan L.
 2009
 27 Supplement 2 p. 5956-5963
8 p.
 artikel
70 Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding Ahmed, Tanvir
 2009
 27 Supplement 2 p. 1433-1439
7 p.
 artikel
71 Enhancement of antitumor immune response by targeted interleukin-12 electrogene transfer through antiHER2 single-chain antibody in a murine bladder tumor model Tsai, Yuh-Shyan
 2009
 27 Supplement 2 p. 5383-5392
10 p.
 artikel
72 Enhancement of the immune responses to vaccination against foot-and-mouth disease in mice by oral administration of an extract made from Rhizoma Atractylodis Macrocephalae (RAM) Li, Ruili
 2009
 27 Supplement 2 p. 2094-2098
5 p.
 artikel
73 Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall Luman, Elizabeth T.
 2009
 27 Supplement 2 p. 2534-2539
6 p.
 artikel
74 Estradiol improves genital herpes vaccine efficacy in mice Pennock, Jeffry W.
 2009
 27 Supplement 2 p. 5830-5836
7 p.
 artikel
75 Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta] Bharati, Kaushik
 2009
 27 Supplement 2 p. 10-16
7 p.
 artikel
76 Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates Flueck, Christian
 2009
 27 Supplement 2 p. 2653-2661
9 p.
 artikel
77 Excess drug prescriptions during influenza and RSV seasons in the Netherlands: Potential implications for extended influenza vaccination Assink, M.D.M.
 2009
 27 Supplement 2 p. 1119-1126
8 p.
 artikel
78 Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines Yong, Michelle
 2009
 27 Supplement 2 p. 3313-3318
6 p.
 artikel
79 Factors conditioning effectiveness of a reminder/recall system to improve influenza vaccination in asthmatic children Esposito, Susanna
 2009
 27 Supplement 2 p. 633-635
3 p.
 artikel
80 Field evaluation of a Mycoplasma bovis bacterin in young dairy calves Maunsell, Fiona P.
 2009
 27 Supplement 2 p. 2781-2788
8 p.
 artikel
81 First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain Ballesteros, C.
 2009
 27 Supplement 2 p. 6662-6668
7 p.
 artikel
82 Foot and mouth disease virus vaccines Rodriguez, Luis L.
 2009
 27 Supplement 2 p. D90-D94
nvt p.
 artikel
83 Ginseng stem–leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice Song, Xiaoming
 2009
 27 Supplement 2 p. 51-55
5 p.
 artikel
84 Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation Pannaraj, Pia S.
 2009
 27 Supplement 2 p. 4452-4456
5 p.
 artikel
85 HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine Ovsyannikova, Inna G.
 2009
 27 Supplement 2 p. 3349-3358
10 p.
 artikel
86 Homologous prime-boost strategy in neonate mice using Neisseria lactamica Ito, André Y.
 2009
 27 Supplement 2 p. 3422-3428
7 p.
 artikel
87 Hospital-based surveillance and molecular epidemiology of rotavirus infection in Taiwan, 2005–2007 Wu, F.T.
 2009
 27 Supplement 2 p. F50-F54
nvt p.
 artikel
88 Human dendritic cell maturation and activation by a heat-killed recombinant yeast (Saccharomyces cerevisiae) vector encoding carcinoembryonic antigen Remondo, Cinzia
 2009
 27 Supplement 2 p. 987-994
8 p.
 artikel
89 Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy Tanzi, Elisabetta
 2009
 27 Supplement 2 p. A17-A23
nvt p.
 artikel
90 Human papillomavirus vaccine decision-making in Da Nang, Vietnam: Perceived spousal and adolescent–parent concordance Breitkopf, Carmen Radecki
 2009
 27 Supplement 2 p. 2367-2371
5 p.
 artikel
91 Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV Jones, Bart
 2009
 27 Supplement 2 p. 1848-1857
10 p.
 artikel
92 Humoral and cellular immune responses to split-virion H5N1 influenza vaccine in young and elderly adults Leroux-Roels, Isabel
 2009
 27 Supplement 2 p. 6918-6925
8 p.
 artikel
93 Humoral immunogenicity to measles, rubella, and varicella-zoster vaccines in biliary atresia children Wu, Jia-Feng
 2009
 27 Supplement 2 p. 2812-2815
4 p.
 artikel
94 Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2 Zhang, Anding
 2009
 27 Supplement 2 p. 1348-1353
6 p.
 artikel
95 Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5 Zhou, Mingguang
 2009
 27 Supplement 2 p. 5271-5277
7 p.
 artikel
96 Identification of a surface protective antigen, HP0197 of Streptococcus suis serotype 2 Zhang, Anding
 2009
 27 Supplement 2 p. 5209-5213
5 p.
 artikel
97 IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants Soininen, Anu
 2009
 27 Supplement 2 p. 2680-2688
9 p.
 artikel
98 IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content Hendrikx, Lotte H.
 2009
 27 Supplement 2 p. 6530-6536
7 p.
 artikel
99 Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial Kanungo, Suman
 2009
 27 Supplement 2 p. 6887-6893
7 p.
 artikel
100 Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease Sorichter, Stephan
 2009
 27 Supplement 2 p. 2755-2759
5 p.
 artikel
101 Immunisation coverage in Australian Indigenous children: Time to move the goal posts O’Grady, Kerry-Ann
 2009
 27 Supplement 2 p. 307-312
6 p.
 artikel
102 Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE–LKT (SAC89) protein Confer, A.W.
 2009
 27 Supplement 2 p. 1771-1776
6 p.
 artikel
103 Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection Sahoo, M.K.
 2009
 27 Supplement 2 p. 4263-4271
9 p.
 artikel
104 Immunization with the 7-valent conjugate pneumococcal vaccine: Impact evaluation, continuing surveillance and future perspectives Bechini, Angela
 2009
 27 Supplement 2 p. 3285-3290
6 p.
 artikel
105 Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: A potential vaccine candidate Rojas-Caraballo, Jose
 2009
 27 Supplement 2 p. 2870-2876
7 p.
 artikel
106 Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial Chiu, Susan S.
 2009
 27 Supplement 2 p. 4834-4839
6 p.
 artikel
107 Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine Gillet, Y.
 2009
 27 Supplement 2 p. 446-453
8 p.
 artikel
108 Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adults Chu, Daniel Wai-Sing
 2009
 27 Supplement 2 p. 7428-7435
8 p.
 artikel
109 Immunogenicity of a novel Stx2B–Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection Gao, Xiang
 2009
 27 Supplement 2 p. 2070-2076
7 p.
 artikel
110 Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopes Gamage, Lakshman N.A.
 2009
 27 Supplement 2 p. 6595-6604
10 p.
 artikel
111 Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis Dey, Ayan
 2009
 27 Supplement 2 p. 5152-5160
9 p.
 artikel
112 Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants Almeida, Volia De Carvalho
 2009
 27 Supplement 2 p. 3856-3861
6 p.
 artikel
113 Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis Valdés, Iris
 2009
 27 Supplement 2 p. 995-1001
7 p.
 artikel
114 Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants Lagos, Rosanna
 2009
 27 Supplement 2 p. 2299-2305
7 p.
 artikel
115 Incremental system costs of introducing combined DTwP–hepatitis B–Hib vaccine into national immunization services in Ethiopia Griffiths, Ulla K.
 2009
 27 Supplement 2 p. 1426-1432
7 p.
 artikel
116 Influence of cytokine gene variations on immunization to childhood vaccines Yucesoy, Berran
 2009
 27 Supplement 2 p. 6991-6997
7 p.
 artikel
117 Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Ovsyannikova, Inna G.
 2009
 27 Supplement 2 p. 3359-3366
8 p.
 artikel
118 Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors Hollmeyer, Helge G.
 2009
 27 Supplement 2 p. 3935-3944
10 p.
 artikel
119 Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy Moran, Kathy
 2009
 27 Supplement 2 p. 2350-2355
6 p.
 artikel
120 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 Tondella, M.L.
 2009
 27 Supplement 2 p. 803-814
12 p.
 artikel
121 Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice Oma, Keita
 2009
 27 Supplement 2 p. 3181-3188
8 p.
 artikel
122 Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets Song, Min-Suk
 2009
 27 Supplement 2 p. 3145-3152
8 p.
 artikel
123 Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine Hammitt, Laura L.
 2009
 27 Supplement 2 p. 7359-7366
8 p.
 artikel
124 Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection Goto, Yasuyuki
 2009
 27 Supplement 2 p. 2884-2890
7 p.
 artikel
125 Local and regional adverse reactions to BCG-SSI® vaccination: A 12-month cohort follow-up study Dommergues, M.A.
 2009
 27 Supplement 2 p. 6967-6973
7 p.
 artikel
126 Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus Sasaki, Takashi
 2009
 27 Supplement 2 p. 5174-5177
4 p.
 artikel
127 Mannose addition by yeast Pichia Pastoris on recombinant HER-2 protein inhibits recognition by the monoclonal antibody herceptin Vlahopoulos, Spiros
 2009
 27 Supplement 2 p. 4704-4708
5 p.
 artikel
128 M2e-based universal influenza A vaccine Fiers, Walter
 2009
 27 Supplement 2 p. 6280-6283
4 p.
 artikel
129 Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization Leifer, Immanuel
 2009
 27 Supplement 2 p. 6522-6529
8 p.
 artikel
130 Molecular epidemiology of G9 rotavirus strains in children with diarrhoea hospitalized in Mainland China from January 2006 to December 2007 Li, Dan-di
 2009
 27 Supplement 2 p. F40-F45
nvt p.
 artikel
131 Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity Khan, Sheema
 2009
 27 Supplement 2 p. 6080-6087
8 p.
 artikel
132 Monoclonal antibody based ELISA tests to detect antibodies against neuraminidase subtypes 1, 2 and 3 of avian influenza viruses in avian sera Moreno, Ana
 2009
 27 Supplement 2 p. 4967-4974
8 p.
 artikel
133 MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis Silva, Bruna Daniella de Souza
 2009
 27 Supplement 2 p. 4402-4407
6 p.
 artikel
134 Mucosal immunity in mice induced by orally administered transgenic rice Zhang, Xiuxiang
 2009
 27 Supplement 2 p. 1596-1600
5 p.
 artikel
135 Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load Hoegh-Petersen, Mette
 2009
 27 Supplement 2 p. 6723-6730
8 p.
 artikel
136 Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens Gómez, Carmen E.
 2009
 27 Supplement 2 p. 3165-3174
10 p.
 artikel
137 National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential Hsieh, Yu-Chia
 2009
 27 Supplement 2 p. 5513-5518
6 p.
 artikel
138 Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea van den Biggelaar, Anita. H.J.
 2009
 27 Supplement 2 p. 1340-1347
8 p.
 artikel
139 Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper Arce-Estrada, Viviana
 2009
 27 Supplement 2 p. 460-466
7 p.
 artikel
140 Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity Sun, Hong-Xiang
 2009
 27 Supplement 2 p. 3984-3991
8 p.
 artikel
141 One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model Fort, M.
 2009
 27 Supplement 2 p. 4031-4037
7 p.
 artikel
142 On the use of hemagglutination-inhibition for influenza surveillance: Surveillance data are predictive of influenza vaccine effectiveness Ndifon, Wilfred
 2009
 27 Supplement 2 p. 2447-2452
6 p.
 artikel
143 Optimized subunit vaccine protects against experimental leishmaniasis Bertholet, Sylvie
 2009
 27 Supplement 2 p. 7036-7045
10 p.
 artikel
144 Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine Henderson, Heather
 2009
 27 Supplement 2 p. 7194-7197
4 p.
 artikel
145 Overcoming innate host resistance to vaccination: Employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception Nikolovski, Sonia
 2009
 27 Supplement 2 p. 5226-5232
7 p.
 artikel
146 Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys Pillai, S.P.S.
 2009
 27 Supplement 2 p. 819-824
6 p.
 artikel
147 Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up Longo, Olimpia
 2009
 27 Supplement 2 p. 3306-3312
7 p.
 artikel
148 Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis Keiser, Paul B.
 2009
 27 Supplement 2 p. 6809-6813
5 p.
 artikel
149 Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells Huaman, Maria Cecilia
 2009
 27 Supplement 2 p. 5239-5246
8 p.
 artikel
150 Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen Xie, Yong
 2009
 27 Supplement 2 p. 757-764
8 p.
 artikel
151 Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa Freeman, Esther E.
 2009
 27 Supplement 2 p. 940-946
7 p.
 artikel
152 Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae Wang, Chunlai
 2009
 27 Supplement 2 p. 5816-5821
6 p.
 artikel
153 Possible autoimmune reactions following smallpox vaccination: The biologic false positive test for syphilis Monath, Thomas P.
 2009
 27 Supplement 2 p. 1645-1650
6 p.
 artikel
154 Predictive value of seizure ICD-9 codes for vaccine safety research Shui, Irene M.
 2009
 27 Supplement 2 p. 5307-5312
6 p.
 artikel
155 Predictors of interest in HPV vaccination: A study of British adolescents Marlow, Laura A.V.
 2009
 27 Supplement 2 p. 2483-2488
6 p.
 artikel
156 Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa Lee, Che-Hung
 2009
 27 Supplement 2 p. 726-732
7 p.
 artikel
157 Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus Biesova, Zuzana
 2009
 27 Supplement 2 p. 6234-6238
5 p.
 artikel
158 Prevention of otitis media: Now a reality? Schuerman, Lode
 2009
 27 Supplement 2 p. 5748-5754
7 p.
 artikel
159 Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model Ahmad, Gul
 2009
 27 Supplement 2 p. 2830-2837
8 p.
 artikel
160 Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep Hamers, C.
 2009
 27 Supplement 2 p. 2789-2793
5 p.
 artikel
161 Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus Guthrie, Alan J.
 2009
 27 Supplement 2 p. 4434-4438
5 p.
 artikel
162 Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses Alberini, Isabella
 2009
 27 Supplement 2 p. 5998-6003
6 p.
 artikel
163 Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines Franka, Richard
 2009
 27 Supplement 2 p. 7149-7155
7 p.
 artikel
164 Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response Mahalanabis, D.
 2009
 27 Supplement 2 p. 4850-4856
7 p.
 artikel
165 Recombinant attenuated Salmonella harboring 4-1BB ligand gene enhances cellular immunity Ye, Jian-xin
 2009
 27 Supplement 2 p. 1717-1723
7 p.
 artikel
166 Recombinant Mycobacterium smegmatis mc 2 155 vaccine expressing outer membrane protein 26kDa antigen affords therapeutic protection against Helicobacter pylori infection Lü, Lin
 2009
 27 Supplement 2 p. 972-978
7 p.
 artikel
167 Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic Simani, Omphile E.
 2009
 27 Supplement 2 p. 146-151
6 p.
 artikel
168 Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination Ohmit, Suzanne E.
 2009
 27 Supplement 2 p. 1050-1054
5 p.
 artikel
169 Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany Rückinger, Simon
 2009
 27 Supplement 2 p. 4136-4141
6 p.
 artikel
170 RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters Widman, Douglas G.
 2009
 27 Supplement 2 p. 5550-5553
4 p.
 artikel
171 Role of lipopolysaccharide in the induction of type I interferon-dependent cross-priming and IL-10 production in mice by meningococcal outer membrane vesicles Durand, Vanessa
 2009
 27 Supplement 2 p. 1912-1922
11 p.
 artikel
172 Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study Phua, K.B.
 2009
 27 Supplement 2 p. 5936-5941
6 p.
 artikel
173 Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age Halperin, Scott A.
 2009
 27 Supplement 2 p. 2540-2547
8 p.
 artikel
174 Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults Brady, Rebecca C.
 2009
 27 Supplement 2 p. 5091-5095
5 p.
 artikel
175 Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study Kaltenböck, A.
 2009
 27 Supplement 2 p. 4483-4489
7 p.
 artikel
176 Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial Launay, Odile
 2009
 27 Supplement 2 p. 1184-1191
8 p.
 artikel
177 Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics Rose, Markus A.
 2009
 27 Supplement 2 p. 5259-5264
6 p.
 artikel
178 Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs Kyriakis, Constantinos S.
 2009
 27 Supplement 2 p. 2258-2264
7 p.
 artikel
179 Scheduling of measles vaccination in low-income countries: Projections of a dynamic model Bauch, C.T.
 2009
 27 Supplement 2 p. 4090-4098
9 p.
 artikel
180 Secreted proteins of Neisseria meningitidis protect mice against infection Li, Yanwen
 2009
 27 Supplement 2 p. 2320-2325
6 p.
 artikel
181 Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies Pírez, María Catalina
 2009
 27 Supplement 2 p. 2689-2694
6 p.
 artikel
182 Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006 Tyrrell, Gregory J.
 2009
 27 Supplement 2 p. 3553-3560
8 p.
 artikel
183 Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry Worrall, E.E.
 2009
 27 Supplement 2 p. 4161-4168
8 p.
 artikel
184 Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets Forrest, Heather L.
 2009
 27 Supplement 2 p. 4187-4195
9 p.
 artikel
185 Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults Schwarz, Tino F.
 2009
 27 Supplement 2 p. 6284-6290
7 p.
 artikel
186 sopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria Nagarajan, Arvindhan G.
 2009
 27 Supplement 2 p. 2804-2811
8 p.
 artikel
187 Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection Haolla, Filipe A.
 2009
 27 Supplement 2 p. 5644-5653
10 p.
 artikel
188 Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age Zaman, K.
 2009
 27 Supplement 2 p. 1333-1339
7 p.
 artikel
189 T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation Zubkova, I.
 2009
 27 Supplement 2 p. 2594-2602
9 p.
 artikel
190 The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes Benferhat, Rima
 2009
 27 Supplement 2 p. 3620-3630
11 p.
 artikel
191 The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides Jones, Hannah E.
 2009
 27 Supplement 2 p. 5806-5815
10 p.
 artikel
192 The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with β-thalassemia Orthopoulos, George V.
 2009
 27 Supplement 2 p. 350-354
5 p.
 artikel
193 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Maciag, Paulo Cesar
 2009
 27 Supplement 2 p. 3975-3983
9 p.
 artikel
194 The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap Heldens, J.G.M.
 2009
 27 Supplement 2 p. 5530-5537
8 p.
 artikel
195 The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts Bucarey, Sergio A.
 2009
 27 Supplement 2 p. 5781-5790
10 p.
 artikel
196 TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity Johnson, Teresa R.
 2009
 27 Supplement 2 p. 3045-3052
8 p.
 artikel
197 TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model Cyr, Sonya L.
 2009
 27 Supplement 2 p. 421-430
10 p.
 artikel
198 Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice Peng, Gao-Hui
 2009
 27 Supplement 2 p. 6570-6574
5 p.
 artikel
199 Transmission-dynamic model to capture the indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine (PCV7)) in older populations Snedecor, Sonya J.
 2009
 27 Supplement 2 p. 4694-4703
10 p.
 artikel
200 Treatment with demethylating agent, 5-aza-2′-deoxycytidine enhances therapeutic HPV DNA vaccine potency Lu, Dan
 2009
 27 Supplement 2 p. 4363-4369
7 p.
 artikel
201 Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology Chow, C.M.
 2009
 27 Supplement 2 p. F55-F60
nvt p.
 artikel
202 Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses Price, Graeme E.
 2009
 27 Supplement 2 p. 6512-6521
10 p.
 artikel
203 Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis Gaston, J. S. Hill
 2009
 27 Supplement 2 p. 5432-5434
3 p.
 artikel
204 Vaccination of Fischer 344 rats against pulmonary infections by Francisella tularensis type A strains Wu, Terry H.
 2009
 27 Supplement 2 p. 4684-4693
10 p.
 artikel
205 Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen Mealey, Robert H.
 2009
 27 Supplement 2 p. 2453-2468
16 p.
 artikel
                             205 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland